A trial to study the effect and molecular mechanism of regorafenib for the treatment of patients with refractory metastatic colorectal cancer (mCRC)
Latest Information Update: 03 Mar 2020
At a glance
- Drugs Regorafenib (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 01 Feb 2020 Results published in the Cancer Science
- 18 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology